Corpus Intelligence IC Memo — HCA FLORIDA OCALA HOSPITAL 2026-04-26 05:22 UTC
IC Memo — HCA FLORIDA OCALA HOSPITAL
Investment Committee Memorandum | FL | 509 beds | Grade B | EBITDA uplift $56.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HCA FLORIDA OCALA HOSPITAL

CCN 100212 | MARION, FL | 509 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

HCA FLORIDA OCALA HOSPITAL is a 509-bed suburban community hospital in MARION, FL with $761.7M in net patient revenue and a 27.6% operating margin. The hospital serves a payer mix of 28.3% Medicare, 7.7% Medicaid, and 64.1% commercial.

Thesis: Platform Growth. Our ML models identify $56.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 27.6% to 34.9% (+736bps).

Net Revenue HCRIS$761.7M
Current EBITDA COMPUTED$209.9M
Operating Margin COMPUTED27.6%
Occupancy HCRIS82.3%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS10.1%
Distress Probability ML40.4%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
75
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 27.6% places it above the state median. Among 75 size-comparable peers (254-1018 beds), the median margin is 5.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (254-1018), prioritizing same-state peers. 75 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HCA FLORIDA OCALA HOSPITAL (Target)FL509$761.7M27.6%
UNIVERSITY OF MIAMI HOSP & CLIFL532$2.36B0.9%
UF HEALTH SHANDSFL994$2.24B10.4%
BAPTIST MEDICAL CENTERFL980$1.78B0.9%
TAMPA GENERAL HOSPITALFL898$1.73B-9.3%
BAPTIST HOSPITALFL948$1.71B10.8%
MEMORIAL REGIONAL HOSPITALFL838$1.45B-20.7%
LEE MEMORIAL HOSPITALFL748$1.28B17.4%
SARASOTA MEMORIAL HOSPITALFL787$1.10B8.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $56.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$16.0M+210bp18mo
Cost to Collect4.5%2.5%$15.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$15.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$9.3M+122bp9mo
Clean Claim Rate88.0%96.0%$487K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$16.0M
Cost to Collect
$15.2M
Denial Rate Reduction
$15.1M
A/R Days Reduction
$9.3M
Clean Claim Rate
$487K
Total EBITDA Uplift$56.1M
Current EBITDA$209.9M
+ RCM Uplift+$56.1M
Pro Forma EBITDA$266.0M
Current Margin27.6%
Pro Forma Margin34.9%
WC Released (1x)$29.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$322.9M$1.95B6.02x43.2%
Base (11x exit)10.0x11.0x$322.9M$2.24B6.95x47.4%
Bull Case9.0x11.0x$290.6M$2.53B8.72x54.2%
Bull (12x exit)9.0x12.0x$290.6M$2.85B9.81x57.9%
Bear Case11.0x10.0x$355.2M$1.56B4.39x34.4%
Bear (11x exit)11.0x11.0x$355.2M$1.83B5.16x38.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 75 hospitals with 254-1018 beds
  • Same-state prioritization (n=76)
  • Comp margins: P25=-5.3% / P50=5.1% / P75=15.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.